Back to VA VANGUARD CAPITAL MANAGEMENT LLC
LTRN2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in LANTERN PHARMA INC
Yes. Vanguard Capital Management holds 425,118 shares of LTRN (Lantern Pharma), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 93,039 shares (+28.0%) from Q1 2026. Vanguard Capital Management has held LTRN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$1.8M
Current Shares
425,118
Total Value Change
+$1.3M
Total Shares Change
+93,039
Quarter-by-Quarter History
Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD GROUP INC